Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical for $2.4B

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, announces that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd. (ONO), under which ONO will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash through a tender offer followed by a merger of Deciphera with a wholly-owned subsidiary of ONO (the “Acquisition”), for a total equity value of $2.4 billion. Together, ONO and Deciphera will accelerate their shared vision to deliver innovative new drugs and serve patients around the world.

Read the full article: Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical for $2.4B //

Source: https://www.businesswire.com/news/home/20240429316382/en/Deciphera-Pharmaceuticals-to-be-Acquired-by-ONO-Pharmaceutical-For-2.4-Billion

Leave a Comment

Your email address will not be published.

Scroll to Top